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Abstract
Background: There is high variability in end-of-life (EOL) treatments. Some of this could be due to differences in
physician treatment recommendations, their knowledge/attitude regarding palliative care, and their perceived roles
in treating patients with advanced serious illness (ASI). Thus, the objective of this paper was to identify potential
variation in physician recommendations, their knowledge/attitude regarding palliative care and perceived roles in
treating ASI patients.
Methods: A cross-sectional survey consisting of vignettes describing patient characteristics that varied by age, expected
survival, cognitive status and treatment costs and asked physicians whether they would recommend life-extending
treatments for each scenario, was administered to 285 physicians who treat ASI patients in Singapore. Physicians were
also assessed on their knowledge/attitude in palliative care. They were administered a best-worst scaling exercise
requiring them to select their most and least important role as a physician caring for an ASI patient.
Results: There was a wide variation in physician recommendations for life-extending treatments for patients with similar
profiles, which can partly be attributed to physician characteristics (years of experience and place of training). Only about
one-fourth of the physicians answered all knowledge/attitude questions correctly. Statements assessing knowledge/
attitude regarding pain management had the fewest correct responses. The most important perceived role regarding
provision of EOL care concerned symptom management.
Conclusions: Results suggest that variation in physician treatment recommendations may be partly related to
their own characteristics, raising concerns regarding the EOL care being provided to patients. Efforts should
be made to better understand this variation and to provide the physicians with additional training in key
aspects of palliative care management.
Keywords: Terminal care, Treatment recommendations, Palliative care, Pain management, Perceived roles, Vignettes,
Best-worst scaling
Background
Variation in medical practice is a common phenomenon
[1, 2] and although understudied, is likely to be large
among patients with advanced serious illnesses (ASI),
such as those with advanced cancers or advanced organ
failures, for which treatment options are largely
restricted to life extension or palliation of symptoms.
Such variation can be appropriate and beneficial if it oc-
curs due to differences in illness characteristics or pa-
tient preferences. However if the variation in treatment
recommendations for these patients, such as whether or
not to recommend a life extending treatment, is inde-
pendent of patient characteristics or preferences, and is
due to physician characteristics or their practice style,
then this raises questions about whether patients are re-
ceiving the best possible care at the end of life (EOL)
and whether healthcare resources are being used
optimally.
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Research documents variation in physician practice
styles or recommendations for a range of services and
conditions [3–11]. Such variation may relate to differ-
ences in cost, [12] patient age, [13] presence of cognitive
impairment, [14] health care systems, [3, 4] cultural or
health care beliefs, [5] and treatment guidelines [6]. The
relationship with patient’s cognitive status may be due to
caregiver or physician attitudes regarding perceived
benefit of treatment to patients with dementia. Equiva-
lent research for ASI patients in Singapore (the setting
for this study), though presently lacking, is likely to indi-
cate that variation in physician practice styles will be
large as patients (and caregivers) often defer to their
physicians for final decisions regarding treatment [7]
and much of the care is paid out-of-pocket [8]. The lat-
ter point is especially salient as the lack of a third party
payer affords physicians greater flexibility in treatment
recommendations, with fewer concerns about coverage,
oversight, and reimbursement guidelines.
Variation in treatment of patients with ASI may also
result from variation in knowledge/attitude and per-
ceived roles of physicians in managing such patients. In
Singapore, most EOL care is provided by non-palliative
care physicians who have little training in palliative care
[9, 10]. Poor knowledge due to absence of training may
result in poor management of patients. Furthermore,
control of pain and other symptoms has traditionally re-
ceived lower priority in care of patients with cancer and
other ASI as compared to extending patient’s life [11].
This may be related to (non-palliative care) physicians’
perception of their role in primarily providing life-
extending treatments as opposed to managing their
symptoms. If so, these physicians may be less likely to
provide palliative care to patients.
It is challenging to identify the causes of variation in
treatment patterns for patients with ASI in the real world
given differences in health status, patient and caregiver
preferences, socio-demographics and other factors. There-
fore, we attempted to address this issue via a carefully
designed survey of physicians who treat patients with ASI
in Singapore. The survey aimed to ascertain the variation
in physician recommendations for life-extending treat-
ments for ASI patients, their knowledge/attitude regarding
palliative care provision and their perceived roles regard-
ing provision of EOL care. We hypothesized that there
will be a large variation in physician recommendations,
which will systematically vary by their characteristics (age,
gender, experience, country of medical training and train-
ing in palliative care), that they will lack appropriate
knowledge/attitude about palliative care provision and
that extending patient’s life for as long as possible will be
the most important perceived role of physicians. If con-
firmed, then this might raise concerns that patients are re-
ceiving sub-optimal care at the EOL.
Methods
Setting and sample
Between June and December 2013, the study team invited
physicians to take the study at departmental meetings for
select departments at the four largest public hospitals in
Singapore, and sent email requests to physicians via elec-
tronic mailing lists maintained by select medical groups.
Departments that are expected to receive large numbers
of ASI patients, e.g., Medicine, Surgery, Oncology,
Cardiology etc. were selected for the study. A convenience
sample of 285 (179 on-line and 106 on paper) physicians
who treat patients with ASI in Singapore responded to the
survey, with the overwhelming majority (93.3 %) coming
from public sector hospitals and clinics. Informed written
consent was obtained from all participants. The study was
approved by the Institutional Review Board at the
National University of Singapore. Dataset for this study is
available on request. A brief description of Singapore’s
health care system is in Additional file 1.
Survey questionnaire
In the first section of the questionnaire, nine vignettes
described a hypothetical patient with ASI. All physicians
answered all of the nine vignettes in the survey ques-
tionnaire. Previous studies have shown vignettes to be a
valid tool in measuring clinical practice variation [12, 13].
Each vignette in our study was identical except for 4 attri-
butes that systematically varied with 3 levels each: patient
age (35, 55, 75 years), median life-extension associated
with the treatment option (4, 12, 24 months), 5-year
survival rate associated with the treatment option (1, 5,
10 %), and cost of the treatment (S$10,000, S$55,000,
S$100,000). The specific attribute levels were selected to
elicit large variation in responses and were pre-tested be-
fore the main survey. The nine vignettes were chosen such
that each attribute level appeared three times and only
once with every other level from other attributes. This ex-
perimental design, generated by Sawtooth SSI web, [14]
allows for estimating unbiased main effects of each level
on choice of outcome. An example vignette is shown in
Table 1, Panel A.
In the next section, physicians were presented with
seven statements (Table 1, Panel B) to assess their know-
ledge/attitude regarding palliative care and pain manage-
ment for patients with ASI and asked to indicate
whether or not each statement was true or false. If their
response matched with the most appropriate response, it
was deemed to be correct. These statements and their
most appropriate responses were generated through a
review of literature and discussion among investigators
and their content was validated by several palliative care
physicians.
Finally, physicians were presented with a best-worst
scaling exercise to elicit their perception about their
Malhotra et al. BMC Palliative Care  (2015) 14:52 Page 2 of 8
Table 1 Example vignette, statements assessing knowledge and perceived roles of physicians
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most and least important roles in treating a patient at
the EOL. Best-worst scaling is a method of eliciting
stated preferences that has been found to be superior in
differentiating between individual preferences as com-
pared to rating or Likert scales [15–17]. In this method,
respondents are asked to make their best and worst
choices from a series of choice sets containing 3 or more
attributes/items. This method assumes that respondents
find it easier to choose between extremes in a set of 3 or
more items. In this survey, we identified 9 physician per-
ceived roles from a review of literature and discussion
amongst investigators. These were pilot tested prior to
fielding. Pilot testing was done to ensure that all state-
ments were clear and relevant for physicians; those un-
clear or were not chosen as either best or worst in any
of the tasks, were subsequently removed or modified.
We then used a balanced incomplete block design [17]
to create 12 choice sets. A balanced incomplete block
design is an experimental design which gives fixed set
sizes (in this case the set size was 3), and each attribute/
item has equal occurrence and co-occurrence (in this
case, each item/role appeared 4 times, every time with
two different roles). This helps to minimize any design-
induced bias. The roles and an example task are in-
cluded in Table 1, Panel C.
Analysis
Vignettes
For vignettes, we calculated the percentage of physicians
recommending treatment for each of the attribute levels
for patients with and without cognitive impairment. We
then ran logistic regression model to estimate the effect of
each attribute level and physician characteristics (gender,
years of experience, palliative care training received and
country of basic medical training) on treatment recom-
mendations. Logistic regression was used as the
dependent variable (whether or not the physician recom-
mends a life extending treatment) is binary. We tested the
model for any specification error (using linktest in
STATA) and goodness-of-fit (Hosmer and Lemeshow's
goodness-of-fit test). Results showed that the model was
adequately specified (linktest was not statistically signifi-
cant) and had good fit (p-value for Hosmer and
Lemeshow’s test = 0.75). Separate model was run for
vignette responses referring to patients with cognitive
impairment.
Knowledge/attitude questions
For the knowledge/attitude questions, the proportion of
physicians who answered correctly on each statement
was first calculated. Since the total number of correct
responses for each physician is a count variable, a pois-
son regression [18]. The independent variables in the
model included physician gender, years of experience,
palliative care training received and country of basic
medical training.
Best-worst scaling
For the best-worst scaling exercise, we calculated an im-
portance score [19] for each role by subtracting the
number of times each role was chosen as being ‘least im-
portant’ from the number of times it was chosen as be-
ing ‘most important’. As each role appears 4 times in the
design, the possible values of these best-worst (B-W)
scores at the individual level ranged from −4 to 4. These
scores were then rescaled to range between 0 and 1.
These importance scores are known to be highly collin-
ear with the estimates from a conventional multinomial
logistic regression or conditional logistic regression
choice model [19].
Results
Physician demographics are presented in Table 2. The
majority (66 %) received no additional training in palliative
care beyond their basic medical school training.
Vignettes
Figure 1 shows the variation in proportions of physicians
recommending life-extending treatment for each attri-
bute level (predicted at the mean of the other levels).
We found that treatment recommendations varied
widely for any given patient profile unless the patient
was assumed to have cognitive impairment. 73 % of phy-
sicians recommended life extending treatment for
Table 2 Physician demographics (n = 285)
Characteristics
Age (in years)







7 year or less 164 (57.5)
More than 7 years 121 (42.5)
Country of Basic Medical Training
Singapore 171 (60.0)
Asia (other than Singapore) 53 (18.6)
Europe, N. America, Australia, New Zealand 50 (17.5)
Additional Training in Palliative Care
None 188 (66.0)
Workshop only 53 (18.6)
Certificate, Diploma or Degree 44 (15.4)
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patients in the best-case scenario that consisted of a
35 year old patient, where treatment would extend life
by 24 months, 5-year survival rate was 10 % and treat-
ment cost was $10,000. In contrast, 40 % of physicians
recommended treatment (and 60 % did not) in the worst
case (i.e., oldest patient, highest treatment cost, worst
prognosis) scenario that consisted of a 75 year old
patient, where treatment would extend life by 4 months,
5-year survival rate was 1 % and treatment cost was
$100,000.
We also find some variation in treatment recommen-
dations by age, treatment costs and prognosis even for
patients with moderate to severe cognitive impairment,
with only 18 % of the physicians recommending treat-
ment in the best-case scenario and 8 % recommending
treatment in the worst-case scenario.
Results from logistic regression (Table 3) show that
physicians are more likely to recommend life-extending
treatments to patients who are younger, have a better
prognosis, and if treatment costs are lower. Furthermore,
physicians with more years of experience were more
likely to recommend life-extending treatment to patients
without cognitive impairment, but were less likely to
recommend treatments to patients with cognitive im-
pairment. Physicians, trained in Europe, North America,
Australia and New Zealand, were more likely to recom-
mend life-extending treatment to patients with cognitive
impairment compared to those trained in Singapore.
Knowledge/attitude questions
Results of the questions (Table 4) show that the percent
of correct answers ranged from 51 to 92 %. The state-
ment assessing prescription of a strong opioid for severe
pain as soon as it is detected had the fewest correct re-
sponses (51 %). Results from the Poisson regression
showed that physicians with greater years of experience
(β = 0.02; p-value = 0.03), those trained in Europe, North
America, Australia, or New Zealand (versus those
trained in Singapore; β = 0.67; p-value = 0.001) and those
with additional training in palliative care (versus those
with no additional training; β = 0.47; p-value = 0.045) had
a greater number of correct responses.
Best-worst scaling
The importance scores from the best-worst exercise
showed that contrary to our hypothesis, the most im-
portant perceived role in treating a patient at the EOL
was treating pain and other physical symptoms, which
was rated most important 84 % of the times it appeared.
On the other hand, the three least important roles per-
ceived by the physicians were withholding diagnosis/
prognosis, extending patient’s life for as long as possible
and discussing treatment costs (Fig. 2).
Discussion
Results show considerable variation in physician recom-
mendations for EOL care, some of which can be pre-
dicted by physician characteristics. If these results
extend to real life, it raises significant concerns as to
whether patients are receiving the most appropriate
treatment at the EOL. Unfortunately, there are no real
world studies that we are aware of to gauge the veracity
of the results. Results further show that lack of appropri-
ate knowledge/attitude in some aspects of palliative care,
reinforcing the need to focus on palliative care education
among non-palliative care physicians.
More experienced physicians were more likely to rec-
ommend life-extending treatments to patients without
cognitive impairment, possibly due to their greater ex-
pertise in use of these treatments. However, with more
Fig. 1 Proportion of physicians recommending life extending treatment for patients with varying characteristics
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experience, there is also a realistic appreciation of patient’s
prognosis and realization of the apparent futility of such
treatments, especially among those with cognitive impair-
ment. Thus experienced physicians become less likely to
recommend life-extending treatments to patients with cog-
nitive impairments. Alternatively, this relationship could
denote a cohort effect, due to younger physicians being
trained in a different medical culture as compared to older
physicians. However, physicians trained outside Asia were
more likely to recommend these treatments to patients
with cognitive impairment. The reason for this is not
known. Nevertheless, study results suggest that if all deci-
sion making were left to physicians, there would likely be
large variation in treatment recommendations even for
similarly situated patients. By eliciting and respecting pa-
tient preferences, it may be possible to minimize variations
in EOL treatments as a result of differences in physician
practice styles or their personal characteristics. Formulation
of standards or guidelines for care and their promotion by
the government or third party payers, perhaps tied to pri-
cing and reimbursement, may also help to reduce practice
variation, as would greater levels of utilization review.
As with our findings, previous studies have also found
that patients with dementia are less likely to be treated for
Table 3 Logistic regression model predicting the odds of recommending life extending treatment, for patients without and with
cognitive impairment, by patient, treatment and physician characteristics
Patients without cognitive impairment Patients with cognitive impairment
Attribute Odds ratio P-value Odds ratio P-value
Age (Reference: 75 years old)
55 years old 3.217 0.000 2.288 0.001
35 years old 6.130 0.000 4.332 0.000
Median life extension (Reference: 4 months)
12 months 6.099 0.000 3.321 0.000
24 months 11.810 0.000 3.910 0.000
5-year survival rate (Reference: 1 %)
5 % 2.165 0.000 1.448 0.130
10 % 3.563 0.000 2.104 0.000
Treatment cost (Reference: $100,000)
$55,000 2.993 0.000 2.503 0.000
$10,000 5.193 0.000 4.024 0.000
Gender (Reference: male)
Female 0.956 0.657 0.992 0.947
Years of experience 1.024 0.000 0.986 0.049
Country of Basic Medical Training (Reference: Singapore)
Asia (other than Singapore) 0.804 0.097 1.034 0.842
Europe / N. America / Australia / New Zealand 1.277 0.067 1.686 0.000
Additional Palliative Care Training (Reference: none)
Workshops on Palliative Care 0.967 0.799 1.050 0.757
Certificate, Diploma, or Degree in Palliative Care 0.905 0.494 0.944 0.752
Table 4 Proportion of physicians with correct answers to each
of the statements assessing their knowledge/ attitude to pain
management and aspects of palliative care
True/False Statement Answer % Correct
It is acceptable for a physician to under-treat
patient’s pain, as prescribing high-dose opioids
can cause respiratory depression.
False 92
Opioids can be prescribed to patients with a
history of substance abuse
True 87
Withdrawing artificial nutrition to imminently
dying patients is not equivalent to
hastening death.
True 74
Increasing requests for analgesics indicate
tolerance to the analgesic.
False 73
Strong opioids are to be administered for
severe pain as soon as it is detected.
True 51
Patients should be referred to palliative care
specialists only when curative/ life-extending
treatment stops working.
False 89
Patients should be referred to palliative care
specialists only when prognosis is less than
6 months.
False 87
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cancer [20–23]. With an increase in prevalence of demen-
tia, physicians can expect to face these decisions more fre-
quently. It is unclear whether life-extending treatments
offer any survival benefit to patients with moderate to se-
vere cognitive impairment, [23] and thus it is difficult to de-
fine what course of treatment will achieve the best possible
medical outcomes for these patients. This is further compli-
cated by the challenge of eliciting patient preferences, as
most patients with serious cognitive impairment lack cap-
acity for decision making and even minor diagnostic and
treatment procedures may cause significant distress to the
patient. Future studies on this topic and development of
guidelines for treatment of ASI among patients with cogni-
tive impairment may help physicians provide clearer guid-
ance to caregivers and work to reduce variation in
physician recommendations.
Despite some evidence that age per se does not influ-
ence the efficacy of many life-extending treatments,
[24–26] we find that physicians are more reluctant to
recommend these treatments to older patients as com-
pared to younger patients, given the same prognosis and
treatment costs. This is consistent with previous litera-
ture reporting an age bias in physician recommendation
of cancer treatments and life-sustaining treatments [27, 28].
It may be that older patients are at a greater risk of adverse
drug reactions, [29] that physicians believe that older
patients may not want as much life-extending treatment
because of fatalist attitudes, or because physicians them-
selves attach lower value to extending life in an older pa-
tient compared to a younger patient. Therefore, efforts
should be made to encourage physicians to discuss patient’s
treatment preferences without being biased by their age.
Treatment costs also influence physician treatment
recommendations; however, physicians did not seem to
view discussing treatment costs with EOL patients as an
important role, possibly because they feel that they do
not have the skills, knowledge, or time to do so or be-
cause they do not see it as their role.
We further show that despite the presence of well-
established guidelines regarding treatment of severe pain,
only 50 % of the physicians surveyed responded
correctly to a statement regarding appropriate opioid
prescription. Furthermore, Singapore trained physi-
cians scored lower compared to physicians trained in
many other developed countries. Insufficient exposure
to palliative care in the undergraduate medical cur-
riculum in Singapore may have contributed to this.
Medical students in Singapore receive only 4 days of
training in palliative care in their entire undergradu-
ate medical curriculum, as compared to an average of
14 days in United States [10, 30, 31]. Basic palliative
care education and training for medical students, resi-
dents, and practicing physicians is needed to fill this
lacuna, and one needs to look into the best models
for incorporating palliative care in training curricula
at various levels.
The study has several limitations. First, it is hypo-
thetical and results may not generalize to real pa-
tients. There is also a lack of clinical detail upon
which to make decisions; more detail may have gener-
ated greater consistency. Moreover, despite promising
confidentiality, it is possible that physician responses
may have been influenced if they felt that they were
being evaluated. It is also possible that framing of
some of the statements in the best-worst tasks could
have influenced physician responses. For instance, the
statement ‘extending patient’s life for as long as pos-
sible’ is worded quite strongly and as a result could
have been consistently underrated by physicians. Fur-
ther, despite every effort to expand this survey to all
major departments in major public hospitals, some of
the departments did not allow or did not have time
for the study team to present in their department
meetings. However, we have no reason to believe
these departments would respond differently. Lastly,
due to the absence of a sampling frame of physicians,
we invited physicians to participate in the survey by
advertising in department meetings and through de-
partment heads and colleagues. Due to different mo-
dalities of invitation and advertisement, it was not
possible to calculate how many physicians received
the invitation to do the survey and hence the re-
sponse rate.
Conclusion
Results from this study suggest that variation in physician
treatment recommendations may be partly related to their
own characteristics. If confirmed, this might raise concerns
regarding the EOL care being provided to patients. Efforts
should be made to better understand the variation in treat-
ment recommendations for similarly situated patients in
specific clinical settings and to provide physicians with
additional training in key aspects of palliative care
management.
Fig. 2 Importance scores on the best-worst scaling exercise
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